Skip to main content
Premium Trial:

Request an Annual Quote

PamGene Says Innogenetics to Introduce HLA Typing on its Array Platform This Year

This article has been updated from a previous version, which incorrectly described Innogenetics as a Dutch company.


VANCOUVER, March 27 (GenomeWeb News) - Innogenetics, a Belgian diagnostics company, will begin offering human leukocyte antigen typing on PamGene's microarray platform later this year, according to a PamGene scientific advisory board member.


Bertrand Jordan, who sits on PamGene's SAB, told GenomeWeb Daily News sister publication BioArray News at the World Microarray Congress here on Friday that Innogenetics is using a system specifically designed for its use called the PamStation 12 to introduce the HLA typing.


The companies began collaborating on the development of the PamStation 12 in May 2004.


Jordansaid that Innogenetics plans to introduce additional tests for the PamStation platform, including tests for cystic fibrosis and the mannose-binding lectin 2 (MBL2) gene in 2007, and for infectious disease, neurodegeneration, oncology, and immunuological diseases in 2008.


Jordansaid the deal is significant for PamGene, and that Innogenetics may use as many as 130 of the PS-12 stations as it adds tests to its menu. PamGene has historically sold systems that run experiments on four arrays or 96 arrays, dubbed the PamStation 4 and PamStation 96, respectively, but Jordan said that the company, which contracts out its manufacturing, was able to design throughput levels to meet the needs of its clients.


Innogenetics does not have exclusive rights to the PS-12, however. "PamGene will be able to sell PS-12 outside of Innogenetics," Jordan said.


Jordansaid that the deal with Innogenetics is significant for PamGene's three-dimensional array technology in the diagnostic arena.


"Array diagnostics still have some difficulty getting into the marketplace due to a lot of competition from RT-PCR," he said.  He added that PamGene's 3D array technology is not yet "mainstream" due to "a lack of high-profile collaborations and papers."   

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.